Vimarsana
Biggest News Aggregation in the World

Page 11 - Relations Contacts News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Relations Contacts. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Relations Contacts Today - Breaking & Trending Today

Marathon Oil Schedules First Quarter 2024 Earnings Release and Conference Call - Vimarsana News

Marathon Oil Schedules First Quarter 2024 Earnings Release and Conference Call

/PRNewswire/ -- Marathon Oil Corporation (NYSE: MRO) announced today it plans to issue its first quarter 2024 earnings release on Wednesday, May 1, after the...

Telesat and Government of Canada Agree to Terms on C$2.14 Billion Loan in Support of Telesat Lightspeed - Vimarsana News

Telesat and Government of Canada Agree to Terms on C$2.14 Billion Loan in Support of Telesat Lightspeed

Government of Canada to receive warrants for 10% of the common shares of Telesat LEO Inc. based upon an equity valuation of US$3 billionOTTAWA, April 01, 2024 -- Telesat , one of the world’s...

Bitfarms : Name and Address of Company - Form 6-K -April 01, 2024 at 04:04 pm EDT - Vimarsana News

Bitfarms : Name and Address of Company - Form 6-K -April 01, 2024 at 04:04 pm EDT

Name and Address of Company Bitfarms Ltd. 110 Yonge Street, Suite 1601 Toronto, Ontario M5C 1T4 ...

Bitfarms Announces March 2024 Production and Operations Update - Vimarsana News

Bitfarms Announces March 2024 Production and Operations Update

- Company earns 286 BTC in March 2024 -- Upgrade and expansion plan, targeting 21 EH/s and 21w/TH in 2024, underway with T21 deliveries and instal...

Galectin Therapeutics Reports 2023 Financial Results and Provides Business Update - Vimarsana News

Galectin Therapeutics Reports 2023 Financial Results and Provides Business Update

29.03.2024 - NORCROSS, Ga., March 29, 2024 (GLOBE NEWSWIRE) - Galectin Therapeutics, Inc. (NASDAQ: GALT), the leading developer of therapeutics that target galectin proteins, today reported financial results and provided a business update for the year ended ...